These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14501946)

  • 81. Dependence of positive effects of granulocyte colony-stimulating factor on the antibiotic regimen: evaluation in rats with polymicrobial peritonitis.
    Bauhofer A; Torossian A; Lorenz W; Middeke M; Plaul U; Schütz P; Stinner B; Hattel M; Celik I
    World J Surg; 2004 Aug; 28(8):834-44. PubMed ID: 15457367
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Granulocyte colony-stimulating factor but not peritoneal lavage increases survival rate after experimental abdominal contamination and infection.
    Bauhofer A; Stinner B; Kohlert F; Reckzeh B; Lorenz W; Celik I
    Br J Surg; 2002 Nov; 89(11):1457-64. PubMed ID: 12390392
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Sickness behavior of rats with abdominal sepsis can be improved by antibiotic and G-CSF prophylaxis in clinic modeling randomized trials.
    Bauhofer A; Schwarting RK; Köster M; Schmitt A; Lorenz W; Pawlak CR
    Inflamm Res; 2004 Dec; 53(12):697-705. PubMed ID: 15654518
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effects of G-CSF and antibiotic prophylaxis in a 2 x 2 factorial design on outcome in septic rats.
    Bauhofer A; Celik I; Plaul U; Wulf H; Torossian A
    Inflamm Res; 2004 Aug; 53 Suppl 2():S126-9. PubMed ID: 15338063
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Granulocyte colony-stimulating factor prophylaxis before operation protects against lethal consequences of postoperative peritonitis.
    Lorenz W; Reimund KP; Weitzel F; Celik I; Kurnatowski M; Schneider C; Mannheim W; Heiske A; Neumann K; Sitter H
    Surgery; 1994 Nov; 116(5):925-34. PubMed ID: 7524176
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The genetic background of hypertensive, septic rats determines outcome improvement with antibiotic and G-CSF prophylaxis.
    Bauhofer A; Tischer B; Middeke M; Plaul U; Lorenz W; Torossian A
    Shock; 2003 Oct; 20(4):326-31. PubMed ID: 14501946
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Recombinant granulocyte colony-stimulating factor (G-CSF) in infectious diseases: still a debate.
    Wiedermann FJ; Mittermayr M; Hoffmann G; Schobersberger W
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):90-6. PubMed ID: 11253746
    [TBL] [Abstract][Full Text] [Related]  

  • 88.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 89.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 90.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 91.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.